PROVIDED HEREIN ARE GINSENOSIDE COMPOSITIONS COMPRISING AT LEAST 10 %(W/W) OF A PROTOPANAXADIOL TYPE OF GINSENOSIDE SUITABLE FOR ADMINISTRATION TO A SUBJECT. ALSO PROVIDED ARE METHODS USING THE GINSENOSIDE COMPOSITIONS FOR REDUCING ACETALDEHYDE CONCENTRATIONS, PREVENTING OR AMELIORATING A SYMPTOM OF ELEVATED ACETALDEHYDE CONCENTRATION, OR REDUCING THE RISK OF DISEASES OR DISORDERS CAUSED BY THE INTAKE OF ETHYL ALCOHOL. THE MOST ILLUSTRATIVE DRAWING IS FIGURE 1